A carregar...
Resisting resistance: Establishing new treatment options for CRPC patients
Overcoming drug resistance in castrate resistant prostate cancer requires improved understanding of mechanisms by which resistance occurs, as well as new treatment options. A recent study published in Nature (Li et al. 2015) examines the mechanism of abiraterone activity, and reveals the bioactivity...
Na minha lista:
Publicado no: | Cancer Biol Ther |
---|---|
Main Authors: | , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Taylor & Francis
2016
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4910910/ https://ncbi.nlm.nih.gov/pubmed/26828765 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2016.1139271 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|